Cancer Supportive Care

Cancer Supportive Care Market Outlook

The global cancer supportive care market was valued at approximately USD 25 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of around 7.2% during the forecast period from 2025 to 2035. This growth can be attributed to an increasing prevalence of cancer worldwide, as well as an expanding recognition of the importance of supportive care in improving patient outcomes and quality of life. Additionally, advancements in treatment modalities, increasing survival rates, and a growing awareness regarding the psychological and physical challenges faced by cancer patients are driving the demand for supportive care products and services. Furthermore, the rise in personalized medicine and integrative therapies is expected to further enhance market growth as patients seek comprehensive care solutions that address their specific needs.

Growth Factor of the Market

The growth of the cancer supportive care market is primarily driven by the increasing prevalence of cancer globally, leading to a higher demand for supportive therapies that can alleviate symptoms and improve the quality of life for patients. Furthermore, the introduction of innovative supportive care medications, nutritional supplements, and rehabilitation services has expanded the options available to patients post-diagnosis and treatment. The growing number of cancer survivors also necessitates ongoing supportive care interventions aimed at managing long-term side effects and psychosocial challenges associated with cancer treatment. In addition, the rise in healthcare spending across both developed and emerging economies has contributed to improved access to supportive care services and products, thus propelling market growth. Moreover, collaborations between healthcare organizations and research institutions in developing new supportive care solutions have further stimulated interest in this market.

Key Highlights of the Market

• Growing awareness about the benefits of supportive care in improving patient outcomes and experience.
• Innovative product launches, including new medications and supplements aimed at managing side effects of cancer treatments.
• Expansion of distribution channels, including the rise of e-commerce platforms catering to cancer patients.
• Emergence of personalized supportive care plans tailored to individual patient needs and conditions.
• Increasing investment in cancer research and supportive care therapies by pharmaceutical companies and nonprofit organizations.

By Product Type

Medications:

Medications play a pivotal role in cancer supportive care, focusing primarily on managing symptoms induced by cancer treatments. These may include anti-nausea drugs, pain management medications, and drugs that stimulate appetite or mitigate fatigue. The development and use of these medications have been crucial in enhancing the overall quality of life for patients undergoing rigorous treatments such as chemotherapy and radiation therapy. With ongoing research and development efforts, new formulations and delivery methods are being introduced, ensuring better patient compliance and effectiveness. This segment is projected to witness significant growth in response to the increasing number of cancer diagnoses and the consequent demand for effective symptom management solutions.

Nutritional Supplements:

Nutritional supplements have emerged as an essential aspect of cancer supportive care, aimed at addressing nutritional deficiencies that often arise due to the disease and its treatment. Supplements such as vitamins, minerals, and herbal preparations are becoming increasingly popular among patients to support overall wellness and boost the immune system. Ingredients like ginger, turmeric, and ashwagandha are gaining traction due to their potential anti-inflammatory and antioxidant properties. Moreover, the rise in consumer awareness regarding health and wellness is contributing to the increasing demand for these supplements, leading to sustained growth in this segment of the market.

Pain Management:

Pain management services in the cancer supportive care market are dedicated to alleviating discomfort that patients frequently experience. This segment encompasses both pharmacological interventions, such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs), and non-pharmacological approaches, including physical therapy and psychological support. The growing emphasis on holistic pain management strategies that address both physical and emotional aspects of pain has led to an increasing number of healthcare providers offering comprehensive pain management plans. As more patients receive cancer diagnoses and treatment, the demand for effective pain management solutions is expected to rise significantly.

Rehabilitation Services:

Rehabilitation services form a critical component of cancer supportive care, assisting patients in recovering physical function and mobility post-treatment. These services may include physical therapy, occupational therapy, and exercise programs tailored specifically for cancer survivors. Rehabilitation can help mitigate the physical side effects of treatments, enabling patients to return to normal daily activities more effectively. The increasing focus on survivorship care and improving long-term outcomes for cancer patients will likely drive growth in this segment, as healthcare systems evolve to incorporate comprehensive rehabilitation into standard cancer care practices.

Counseling Services:

Counseling services are essential for addressing the emotional and psychological impact that a cancer diagnosis has on patients and their families. This segment encompasses psychological counseling, support groups, and behavioral therapy aimed at helping patients cope with anxiety, depression, and stress associated with cancer treatment. As awareness grows regarding the mental health aspects of cancer survivorship, the demand for these supportive services is anticipated to increase significantly. Additionally, integrating counseling services into comprehensive cancer care plans ensures a more holistic approach to treatment, promoting overall well-being and resilience among patients.

By Application

Chemotherapy Support:

Chemotherapy support is a significant application area within the cancer supportive care market, focusing on managing the myriad side effects experienced by patients undergoing chemotherapy treatment. Supportive care interventions in this area include medications to alleviate nausea and vomiting, nutritional support to counteract weight loss, and counseling services to help manage psychological stress. The market for chemotherapy support is projected to grow as more patients are diagnosed with cancer and receive chemotherapy as a primary treatment modality. Furthermore, advancements in antiemetic therapies and ongoing research to improve patient experiences during chemotherapy sessions are expected to bolster this segment.

Radiation Therapy Support:

The support required during and after radiation therapy is crucial, as patients often face side effects such as skin irritation, fatigue, and other systemic effects. Supportive care interventions for radiation therapy focus on alleviating these symptoms and improving patients' overall quality of life. The increasing number of patients undergoing radiation therapy, coupled with the development of new supportive products and services, is likely to drive significant growth in this segment. This includes enhanced skin care products, nutritional supplements, and psychological support tailored specifically for those undergoing radiation treatments.

Surgery Support:

Surgery support in the cancer supportive care market is critical to ensuring patients recover optimally post-surgery. This includes managing pain, providing nutritional support, and facilitating rehabilitation services to restore normal functioning. The emphasis on a multidisciplinary approach to patient care has led to increased attention on postoperative supportive care strategies. As surgical techniques evolve and more patients undergo surgical interventions for cancer treatment, the demand for comprehensive surgery support services is expected to rise, thereby driving growth in this application segment.

Palliative Care:

Palliative care is an essential aspect of cancer supportive care, focusing on improving the quality of life for patients with serious illness by addressing physical, emotional, and spiritual needs. This segment encompasses a wide range of services, including pain management, psychological support, and assistance with end-of-life planning. The growing recognition of the importance of palliative care in cancer treatment has led to increased investment in this area. As healthcare providers strive to offer patient-centered care and support for patients throughout their cancer journey, the demand for effective palliative care solutions is expected to grow.

Survivorship Care:

Survivorship care is becoming an increasingly vital component of the cancer supportive care landscape, as more patients are living longer post-diagnosis. This involves addressing the long-term physical and psychological effects of cancer treatment, including fatigue, pain, and anxiety. Supportive services in this area may include rehabilitation, nutritional guidance, and emotional counseling to ensure a comprehensive approach to survivorship. The emphasis on survivorship care is expected to drive growth in this segment as patients require ongoing support to maintain their health and well-being after completing cancer treatment.

By Distribution Channel

Hospitals:

Hospitals remain a primary distribution channel for cancer supportive care products and services, providing comprehensive care to patients undergoing various cancer treatments. Hospitals typically offer a wide range of supportive care services, including pain management, nutritional support, and rehabilitation. The presence of multidisciplinary teams within hospitals allows for a holistic approach to patient care, addressing both physical and emotional needs. As the number of cancer patients continues to rise, hospitals are expected to play a significant role in the distribution of supportive care solutions, thereby driving growth in this channel.

Cancer Treatment Centers:

Cancer treatment centers are specialized facilities dedicated to providing comprehensive cancer care, including supportive care services. These centers often use a multidisciplinary approach, integrating medical treatments with supportive therapies to enhance patient outcomes. The availability of specialized staff, such as nutritionists and counselors, ensures that patients receive tailored support during their cancer journey. As the demand for specialized cancer care continues to grow, cancer treatment centers are increasingly becoming prominent distribution channels for supportive care products and services.

Retail Pharmacies:

Retail pharmacies are emerging as accessible distribution channels for cancer supportive care products, providing patients with essential medications, nutritional supplements, and over-the-counter remedies to manage treatment side effects. The convenience of local pharmacies allows patients to easily access supportive care solutions without the need for hospital visits. Furthermore, pharmacists are increasingly taking on active roles in patient education and counseling, helping patients navigate their supportive care needs effectively. As the trend towards self-care and home-based management continues to rise, the role of retail pharmacies in the cancer supportive care market is expected to expand significantly.

E-commerce:

The emergence of e-commerce has revolutionized the distribution of cancer supportive care products, providing patients with convenient access to medications, supplements, and educational resources. Online platforms enable patients to find specialized products tailored to their needs, often with the added benefit of home delivery. Additionally, e-commerce allows for a broader range of products, including organic and natural supplements that may not be available in traditional retail settings. As patients increasingly seek the convenience and discretion offered by online shopping, the e-commerce channel is projected to experience substantial growth in the cancer supportive care market.

By Ingredient Type

Ginger:

Ginger is widely recognized for its therapeutic properties, making it a popular ingredient in cancer supportive care products. Its anti-inflammatory and anti-nausea effects are particularly beneficial for patients undergoing chemotherapy, as it can help alleviate some of the common side effects associated with cancer treatments. Moreover, ginger is often used in various forms such as teas, supplements, and extracts, allowing for versatile application in supportive care. The increasing consumer awareness about natural remedies and holistic approaches to health is likely to drive the demand for ginger-based products in this market segment.

Turmeric:

Turmeric, known for its active compound curcumin, has gained recognition for its potential anti-cancer properties and is frequently incorporated into cancer supportive care formulations. Its antioxidant and anti-inflammatory benefits make it a valuable addition for managing inflammation and promoting overall health in cancer patients. The growing trend towards herbal and natural supplements in conjunction with conventional therapies has spurred interest in turmeric-based products, with many patients seeking to enhance their treatment regimens with natural ingredients. This segment is expected to see a surge in growth as research continues to unveil the health benefits of turmeric.

Green Tea:

Green tea is celebrated for its rich antioxidant content, particularly catechins, which are believed to possess potential anti-cancer properties. This ingredient is commonly included in dietary supplements and functional foods aimed at improving the health of cancer patients. The recognition of green tea's potential benefits has led to an increasing incorporation of this ingredient into supportive care protocols. As consumers continue to seek natural approaches to health and wellness, the demand for green tea-based supportive products is expected to grow significantly within the cancer supportive care market.

Ashwagandha:

Ashwagandha is an adaptogenic herb known for its ability to help the body cope with stress, making it a valuable addition to cancer supportive care regimens. Its potential to reduce anxiety and improve overall well-being makes it particularly appealing for patients experiencing the psychological toll of a cancer diagnosis. The increase in interest surrounding herbal remedies and adaptogens in recent years has led to a rise in the development of ashwangandha-infused products aimed at cancer patients. This segment is projected to see significant growth as awareness of the benefits of stress management in cancer care continues to spread.

Ginseng:

Ginseng is a well-known herb often associated with health promotion and vitality, and it is increasingly being utilized in cancer supportive care products. It is believed to enhance energy levels, improve immune function, and reduce fatigue, which are essential for individuals undergoing cancer treatments. The growing interest in natural and herbal solutions for managing treatment side effects is likely to drive demand for ginseng-based products in the supportive care market. As research continues to explore the potential benefits of ginseng for cancer patients, this segment is expected to experience substantial growth.

By Region

The cancer supportive care market displays significant regional variations, with North America holding the largest share primarily due to the high prevalence of cancer, advanced healthcare infrastructure, and increasing awareness of supportive care practices. The region is expected to continue to lead the market, driven by ongoing innovation in supportive care products and services. According to industry projections, North America is anticipated to witness a CAGR of around 7.5% from 2025 to 2035, reflecting the growing emphasis on improving patient outcomes and quality of life in cancer care. Additionally, the presence of major pharmaceutical companies and research institutions enhances the availability and accessibility of innovative supportive care solutions in this region.

Europe is another significant market for cancer supportive care, with a growing recognition of the importance of holistic patient-centered care. The region has witnessed an increase in collaborative efforts between healthcare providers and organizations focusing on survivorship and supportive care initiatives. As more patients in Europe seek comprehensive care approaches, the demand for supportive care products and services is expected to rise. The Asia Pacific region is also experiencing growth in the cancer supportive care market, particularly in countries like China and India, where increasing cancer incidence, a rising population, and improving healthcare infrastructure contribute to expanding opportunities in this field. The Latin America and Middle East & Africa regions, while smaller in market share, are gradually evolving as awareness regarding supportive care increases.

Opportunities

The cancer supportive care market presents numerous opportunities for growth, particularly as healthcare systems worldwide recognize the critical role of supportive care in enhancing patient outcomes. The increasing incidence of cancer, coupled with advancements in treatment modalities, creates a persistent demand for supportive care products and services aimed at alleviating side effects and improving the quality of life for patients. Additionally, the rise in patient-focused approaches to healthcare is leading to innovative product development, with more companies investing in research to create tailored supportive care solutions that meet specific patient needs. Furthermore, the growing trend towards integrative medicine, which combines conventional treatments with complementary therapies, offers an avenue for supportive care products to gain acceptance and utilization within mainstream treatment protocols. This trend aligns well with the preferences of patients seeking comprehensive care solutions that address both physical and emotional aspects of their cancer journey.

Moreover, the expansion of distribution channels, including e-commerce platforms, presents an opportunity for companies to reach a broader audience. E-commerce provides greater accessibility for patients seeking cancer supportive care products, particularly in regions where traditional healthcare facilities may be limited. This shift towards online shopping can drive sales growth and increase patient engagement with supportive care solutions. Additionally, collaborations between pharmaceutical companies, healthcare providers, and research institutions to develop and promote supportive care initiatives can further enhance awareness and utilization of these services. By leveraging technological advancements and consumer insights, stakeholders in the cancer supportive care market can capitalize on the growing demand for innovative products and services, ensuring sustained growth in the coming years.

Threats

Despite the promising growth trajectory of the cancer supportive care market, several threats could potentially hinder its progress. One significant concern is the increasing cost of healthcare and the financial burden it places on patients seeking cancer treatment and supportive care. High out-of-pocket expenses for medications and therapies may limit access to essential supportive care products, particularly for low-income patients or those without adequate insurance coverage. Additionally, the presence of counterfeit products in the market poses a considerable threat to patient safety and can undermine the credibility of supportive care solutions. Regulatory challenges and variations in product approval processes across regions may further complicate market dynamics, creating barriers for new entrants and established players alike.

Another potential threat stems from the intense competition within the healthcare industry, which may lead to price wars and reduced profit margins for companies in the cancer supportive care market. The emergence of alternative therapies and complementary treatments may also divert attention and funding away from conventional supportive care solutions, impacting market growth. Moreover, fluctuations in raw material prices and supply chain disruptions can create challenges for manufacturers in maintaining consistent product quality and availability. Addressing these threats will require proactive strategies, including enhancing patient education on the importance of supportive care, advocating for improved insurance coverage, and ensuring the integrity of products in the market to build trust with patients and healthcare providers.

Competitor Outlook

• Amgen Inc.
• Bristol-Myers Squibb Company
• Roche Holding AG
• Merck & Co., Inc.
• Eli Lilly and Company
• Novartis AG
• Johnson & Johnson
• Pfizer Inc.
• Seattle Genetics, Inc.
• Celgene Corporation
• Takeda Pharmaceutical Company Limited
• Gilead Sciences, Inc.
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• AbbVie Inc.

The competitive landscape of the cancer supportive care market is characterized by significant activities among key players who are continually striving to innovate and enhance their product offerings. Established pharmaceutical and biotech companies play a crucial role in the market due to their extensive resources, research capabilities, and ability to develop new supportive care solutions. These companies often collaborate with healthcare providers, research institutions, and non-profit organizations to identify unmet needs and create comprehensive supportive care programs tailored to patients at various stages of their cancer journey. The increasing focus on personalized medicine has also spurred competition as companies seek to create targeted interventions that address specific patient populations and their unique challenges.

Major companies like Amgen and Bristol-Myers Squibb are investing heavily in research and development to expand their portfolios of supportive care medications and therapies. By leveraging their expertise in oncology, these companies are able to create innovative solutions that not only target cancer cells but also alleviate the associated side effects patients experience during treatment. Additionally, companies like Roche and Merck are actively pursuing partnerships with startups and research entities to drive the development of novel supportive care products that integrate holistic approaches with traditional methodologies. This collaborative environment enhances the overall effectiveness of supportive care and underscores the importance of addressing both the physical and emotional facets of cancer treatment.

Furthermore, emerging players in the cancer supportive care market are gaining traction by focusing on natural and alternative therapies that appeal to consumers' growing preference for integrative approaches to health. Companies specializing in herbal supplements and nutraceuticals are capitalizing on the increasing demand for natural solutions that can complement conventional treatments, such as those derived from turmeric, ginger, and other botanicals. These businesses are focused on building strong distribution networks, particularly via e-commerce platforms, to improve patient access to their products. As the competitive landscape continues to evolve, the ability to adapt to changing consumer preferences and regulatory landscapes will be paramount for all players in the cancer supportive care market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Amgen Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 AbbVie Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Novartis AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Pfizer Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Sanofi S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Holding AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Merck & Co., Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Celgene Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Eli Lilly and Company
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Gilead Sciences, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Seattle Genetics, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bristol-Myers Squibb Company
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Teva Pharmaceutical Industries Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Takeda Pharmaceutical Company Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Cancer Supportive Care Market, By Application
    • 6.1.1 Chemotherapy Support
    • 6.1.2 Radiation Therapy Support
    • 6.1.3 Surgery Support
    • 6.1.4 Palliative Care
    • 6.1.5 Survivorship Care
  • 6.2 Cancer Supportive Care Market, By Product Type
    • 6.2.1 Medications
    • 6.2.2 Nutritional Supplements
    • 6.2.3 Pain Management
    • 6.2.4 Rehabilitation Services
    • 6.2.5 Counseling Services
  • 6.3 Cancer Supportive Care Market, By Ingredient Type
    • 6.3.1 Ginger
    • 6.3.2 Turmeric
    • 6.3.3 Green Tea
    • 6.3.4 Ashwagandha
    • 6.3.5 Ginseng
  • 6.4 Cancer Supportive Care Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Cancer Treatment Centers
    • 6.4.3 Retail Pharmacies
    • 6.4.4 E-commerce

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Cancer Supportive Care Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Cancer Supportive Care market is categorized based on

By Product Type

• Medications
• Nutritional Supplements
• Pain Management
• Rehabilitation Services
• Counseling Services

By Application

• Chemotherapy Support
• Radiation Therapy Support
• Surgery Support
• Palliative Care
• Survivorship Care

By Distribution Channel

• Hospitals
• Cancer Treatment Centers
• Retail Pharmacies
• E-commerce

By Ingredient Type

• Ginger
• Turmeric
• Green Tea
• Ashwagandha
• Ginseng

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Amgen Inc.
• Bristol-Myers Squibb Company
• Roche Holding AG
• Merck & Co., Inc.
• Eli Lilly and Company
• Novartis AG
• Johnson & Johnson
• Pfizer Inc.
• Seattle Genetics, Inc.
• Celgene Corporation
• Takeda Pharmaceutical Company Limited
• Gilead Sciences, Inc.
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• AbbVie Inc.